ArticlePoultry science2026
The amplification of bacteriophages using Salmonella YB1 as a host and its therapeutic efficacy against salmonellosis in broilers.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The residual bacteria in bacteriophage (phage) preparations have hindered their application in poultry disease. We isolated eight phages from aquatic environment samples and selected two phages (vB_StyS_SP03 and vB_StyM_SP07) for amplification using the diaminopimelic acid (DAP)-dependent Salmonella YB1 strain. Both healthy and Salmonella-infected broilers were intraperitoneally injected with phages amplified by Salmonella YB1 and their cocktail to evaluate the safety and therapeutic efficacy. The results showed that Salmonella YB1 effectively amplified phages, whose form and function remained unchanged after amplification. Salmonella YB1 in the phage preparations did not proliferate without DAP supplementation. Phage administration caused no mortality, and did not significantly affect the weight gain, immune organ indexes, and gut microbiota composition in healthy broilers. In Salmonella-challenged broilers, phage administration significantly improved weight gain, reduced organ indexes, alleviated clinical symptoms and pathological changes, and restored the intestinal microbial community. Collectively, we have developed a method for amplifying phages using Salmonella YB1, which effectively addresses the problem of residual bacteria in phage preparations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.